YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
* Genflow Biosciences press release [https://seekingalpha.com/pr/20666624-genflow-biosciences-plc-announces-half-year-financial-report] (GENFF [https://seekingalpha.com/symbol/GENFF]): 1H GAAP EPS of -£0.08. * As of 30 June 2026, the Group…
Genflow Biosciences raises £800,000 to fund gene therapy programmes Proactive uses images sourced from Shutterstock Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the biotechnology company focused on gene therapies for age-relat…
Genflow Biosciences: AGM and partnership strategy - ICYMI Proactive uses images sourced from Shutterstock Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regar…
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) jumped nearly 20% after positive interim results from its aged dog trial. Treated dogs showed better survival and muscle health, with no adverse events reported so far. IXICO PLC (AI…
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNI…
Genflow to Attend the 44th Annual J.P. Morgan Healthcare Conference LONDON, UK / ACCESS Newswire / December 11, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), a leading European-based biotechnology com…
Genflow Biosciences (OTCQB:GENFF [https://seekingalpha.com/symbol/GENFF]) on Wednesday announced [https://seekingalpha.com/pr/20274702-genflow-biosciences-plc-announces-second-european-patent-application]that its second European patent app…
Successful first regulatory interaction with the Federal Agency for Medicines and Health Products (FAHMP) And Internal Debt Restructuring First regulatory agency interaction results in recommendation to commence Phase I/II Clinical Trial i…